These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35283703)

  • 1. Characteristics and Management of Papillary Thyroid Microcarcinoma in the United Arab Emirates: Experience from a Large Tertiary Hospital.
    Malik AA; Aziz F; Beshyah SA; Aldahmani KM
    Saudi J Med Med Sci; 2022; 10(1):42-48. PubMed ID: 35283703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center.
    Kanokwongnuwat W; Larbcharoensub N; Sriphrapradang C; Suppasilp C; Thamnirat K; Sakulpisuti C; Kositwattanarerk A; Utamakul C; Sritara C; Chamroonrat W
    Endocrine; 2022 Jun; 77(1):134-142. PubMed ID: 35476179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial thyroidectomy for papillary thyroid microcarcinoma: Is completion total thyroidectomy indicated?
    Dobrinja C; Pastoricchio M; Troian M; Da Canal F; Bernardi S; Fabris B; de Manzini N
    Int J Surg; 2017 May; 41 Suppl 1():S34-S39. PubMed ID: 28506411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.
    Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in radioiodine use but not total thyroidectomy in thyroid cancer patients treated in the United Arab Emirates - A retrospective study.
    Azhar M; Aziz F; Almuhairi S; Alfelasi M; Elhouni A; Syed R; Al-Shamsi HO; Aldahmani KM
    Ann Med Surg (Lond); 2021 Apr; 64():102203. PubMed ID: 33747499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term oncologic outcomes of papillary thyroid microcarcinoma according to the presence of clinically apparent lymph node metastasis: a large retrospective analysis of 5,348 patients.
    Choi JB; Lee WK; Lee SG; Ryu H; Lee CR; Kang SW; Jeong JJ; Nam KH; Lee EJ; Chung WY; Jo YS; Lee J
    Cancer Manag Res; 2018; 10():2883-2891. PubMed ID: 30214283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma.
    Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
    Front Endocrinol (Lausanne); 2019; 10():363. PubMed ID: 31275239
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study.
    Yan L; Zhang M; Song Q; Xie F; Luo Y
    Eur Radiol; 2022 Feb; 32(2):1216-1226. PubMed ID: 34357450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
    Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
    Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the ATA Risk Stratification Apply to Patients with Papillary Thyroid Microcarcinoma?
    Stefanova DI; Bose A; Ullmann TM; Limberg JN; Finnerty BM; Zarnegar R; Fahey TJ; Beninato T
    World J Surg; 2020 Feb; 44(2):452-460. PubMed ID: 31605172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathological characteristics of incidental and nonincidental papillary thyroid microcarcinoma in 339 patients.
    Vasileiadis I; Karatzas T; Vasileiadis D; Kapetanakis S; Charitoudis G; Karakostas E; Kouraklis G
    Head Neck; 2014 Apr; 36(4):564-70. PubMed ID: 23780707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and therapeutic outcomes of patients with papillary thyroid microcarcinomas and larger tumors.
    Zheng W; Wang X; Rui Z; Wang Y; Meng Z; Wang R
    Nucl Med Commun; 2019 May; 40(5):477-483. PubMed ID: 30973839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillary thyroid carcinoma micro-deposits in cervical lymph nodes without intra-thyroid malignancy: A comment in consideration of the latest American Thyroid Association guidelines.
    Karvounis E; Kechagias A; Kappas I; Ioakimidou C; Fillipidis T
    Mol Clin Oncol; 2021 Aug; 15(2):164. PubMed ID: 34194742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound-Guided Radiofrequency Ablation Versus Surgery for Low-Risk Papillary Thyroid Microcarcinoma: Results of Over 5 Years' Follow-Up.
    Zhang M; Tufano RP; Russell JO; Zhang Y; Zhang Y; Qiao Z; Luo Y
    Thyroid; 2020 Mar; 30(3):408-417. PubMed ID: 31910107
    [No Abstract]   [Full Text] [Related]  

  • 16. Papillary thyroid microcarcinoma: a surgical perspective.
    Sakorafas GH; Giotakis J; Stafyla V
    Cancer Treat Rev; 2005 Oct; 31(6):423-38. PubMed ID: 16005155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of thyroidectomy and lymphadenectomy in 254 patients with papillary thyroid microcarcinoma: a single-institution experience.
    Besic N; Zgajnar J; Hocevar M; Petric R
    Ann Surg Oncol; 2009 Apr; 16(4):920-8. PubMed ID: 19189188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma.
    Lin DZ; Qu N; Shi RL; Lu ZW; Ji QH; Wu WL
    Onco Targets Ther; 2016; 9():5307-16. PubMed ID: 27601922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Papillary thyroid microcarcinoma. Long-term outcome in 587 cases compared with published data].
    Pelizzo MR; Merante Boschin I; Toniato A; Piotto A; Bernante P; Pagetta C; Casal Ide E; Mazzarotto R; Casara D; Rubello D
    Minerva Chir; 2007 Oct; 62(5):315-25. PubMed ID: 17947943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
    Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
    World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.